about
Black yeasts and their filamentous relatives: principles of pathogenesis and host defensePhaeohyphomycoses, emerging opportunistic diseases in animals.Waterborne Exophiala species causing disease in cold-blooded animals.Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.Effects of low-level laser irradiation on the pathogenicity of Candida albicans: in vitro and in vivo study.Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelIn vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.Neglected fungal zoonoses: hidden threats to man and animals.Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in mice.Epidemiological changes in tinea capitis over the sixty years of economic growth in China.Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrumAspergillus and aspergilloses in wild and domestic animals: a global health concern with parallels to human disease.Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.Conventional Morphology Versus PCR Sequencing, rep-PCR, and MALDI-TOF-MS for Identification of Clinical Aspergillus Isolates Collected Over a 2-Year Period in a University Hospital at Kayseri, Turkey.Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection.Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosisDiscrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays.Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens.Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole.Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR.Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies.Systemic Antifungal Agents: Current Status and Projected Future Developments.A 9-Month-Old Girl from Iran with Extensive Erythematous Plaques Due to Trichophyton simii, a Zoophilic Dermatophyte.Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species.Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.Aspergillus fumigatus alkaline protease 1 (Alp1/Asp f13) in the airways correlates with asthma severity.Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.In Vivo Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive Aspergillosis.
P50
Q27028032-2B998327-658D-47CA-972C-45702FC066F0Q30585034-7F5B8604-05C8-43A4-8143-3F1081784D2EQ34189208-6B3BF336-61B5-4DAD-98A5-E0957112EF84Q35076830-C48A2C9D-1A8F-4167-81EC-F29BAE5DCB12Q35136368-50B54B2E-1F6A-4C30-8525-6A1501827472Q35168955-0756913A-F32A-4F5D-B1D4-40058C568D0CQ35183050-A0E83F85-C9BC-4BB4-A8E6-E30A971A2A06Q35385554-F3040B91-0CCD-4FD4-8689-4726159651A6Q35506255-E6AF5F8B-84B8-4AEF-8CF3-7B1BC60C4586Q35577114-D8C6A3D9-2267-43DE-B33C-70F79CBBCF83Q35607735-2965220D-ADA6-47C8-8FFA-C716FC94CA98Q35742042-36C2D6EB-3FB6-400A-89E0-0C950F370D09Q35746245-084ED5E2-DE00-4F42-9B28-77CE0DC1ECB8Q35758334-8EB21DB8-0BCA-44FD-9CC9-BC29C1AA1583Q35911359-E3F39DCE-7309-4533-8108-8A04E950A42DQ35939584-C81629DF-5AE3-430A-BE15-97ABC8FD6173Q36006537-5C242E80-38C6-4C69-B6AA-32C0F5D03845Q36439179-2B4642F2-9DAC-4C7B-95EC-830ABC8CF308Q36439193-06329ABE-EA07-4D3B-997C-505251BC14D7Q36505281-64AAF738-4035-4F9E-9164-5F8A99D7C59AQ36558484-78E02F31-FD29-43CF-878E-446E3F6A9AD7Q36757621-CF72DDB3-B48F-4037-B040-7B2A6CD1DE2DQ37363438-214029F2-9DFB-4992-B634-CD68BB9D54C4Q37538782-F650ABCF-7E5A-45D5-A68C-7140F4A0AA60Q37713035-0EE8EE6A-7F58-43B0-AEE1-303DB884671CQ37738989-943A4E30-611C-4244-8B08-BF87C70BEB06Q37926156-4321B4DF-5BE6-4422-8289-1FB2F2D6B44FQ38140015-F5062BDB-A2AE-476B-A910-1EE9E67455A0Q38234496-60669CB5-BD6E-4572-99D9-8D66BB9E14BFQ38285488-B14ABB75-FC98-45B9-9791-B3C2A14AF516Q38580296-1D61901E-746B-4CA2-83DF-F95FF8305361Q38796140-67859CD3-9975-4C22-8B88-DD4EBEBFAC59Q38876507-EE4DB338-DD98-4761-B259-DD6F461C4AB1Q38876515-BF0CEE97-7296-44FB-8DFE-222DD783776EQ38914243-A150C6E6-7271-40F1-9B92-C639B3CAFE26Q39395182-0F541613-025E-4879-A527-6D8737A58F46Q39504883-2BEE47C6-0F3F-4074-9887-0BD8667D8412Q40062029-AB31632F-E157-4C0A-B9BA-4DAA56AE5E10Q40141118-13308A40-9F0F-4CDF-9994-29A1B7193018Q40248126-47816E3B-5458-41F4-B2D9-8AC4D1AE78B4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Seyedmojtaba Seyedmousavi
@ast
Seyedmojtaba Seyedmousavi
@en
Seyedmojtaba Seyedmousavi
@es
Seyedmojtaba Seyedmousavi
@nl
Seyedmojtaba Seyedmousavi
@sl
type
label
Seyedmojtaba Seyedmousavi
@ast
Seyedmojtaba Seyedmousavi
@en
Seyedmojtaba Seyedmousavi
@es
Seyedmojtaba Seyedmousavi
@nl
Seyedmojtaba Seyedmousavi
@sl
altLabel
Dr. Amir Seyedmousavi
@en
prefLabel
Seyedmojtaba Seyedmousavi
@ast
Seyedmojtaba Seyedmousavi
@en
Seyedmojtaba Seyedmousavi
@es
Seyedmojtaba Seyedmousavi
@nl
Seyedmojtaba Seyedmousavi
@sl
P1053
O-9267-2016
P106
P1153
53865505000
P31
P3829
P496
0000-0002-6194-7447